On December 31, 2012, Regeneron Pharmaceuticals (REGN) had a market capitalization of $20B, based on 117.24M shares at a price of $170.34.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2012 | $170.34 | 16,572,900 | 117,237,000 | $19,970,127,132.60 |
November 2012 | $175.80 | 19,225,100 | 117,237,000 | $20,609,842,546.80 |
October 2012 | $141.69 | 16,418,200 | 117,237,000 | $16,611,615,346.20 |
September 2012 | $152.01 | 13,476,500 | 115,830,000 | $17,607,121,389.00 |
August 2012 | $147.42 | 13,983,400 | 115,830,000 | $17,075,426,940.00 |
July 2012 | $134.08 | 17,525,800 | 115,830,000 | $15,529,930,416.00 |
June 2012 | $113.73 | 22,006,300 | 110,167,000 | $12,529,557,310.80 |
May 2012 | $135.07 | 22,426,100 | 110,167,000 | $14,880,366,857.00 |
April 2012 | $134.68 | 18,294,200 | 110,167,000 | $14,837,577,994.20 |
March 2012 | $116.12 | 17,282,900 | 107,734,000 | $12,510,309,094.80 |
February 2012 | $104.34 | 30,846,600 | 107,734,000 | $11,241,256,441.80 |
January 2012 | $90.47 | 31,221,600 | 107,734,000 | $9,746,921,221.40 |
December 2011 | $55.19 | 32,233,500 | 93,446,000 | $5,157,602,456.40 |
November 2011 | $59.17 | 20,724,700 | 93,446,000 | $5,528,863,414.40 |
October 2011 | $55.06 | 27,384,900 | 93,446,000 | $5,145,501,199.40 |
September 2011 | $57.95 | 35,667,900 | 91,046,000 | $5,276,261,373.60 |
August 2011 | $58.78 | 30,218,800 | 91,046,000 | $5,351,501,788.00 |
July 2011 | $52.83 | 14,231,800 | 91,046,000 | $4,810,278,841.00 |
June 2011 | $56.47 | 19,989,500 | 90,436,000 | $5,106,731,004.40 |
May 2011 | $59.76 | 22,633,900 | 90,436,000 | $5,404,799,016.80 |
April 2011 | $50.82 | 44,174,700 | 90,436,000 | $4,596,147,435.60 |
March 2011 | $44.75 | 10,827,500 | 89,162,000 | $3,989,839,008.40 |
February 2011 | $36.12 | 11,849,500 | 89,162,000 | $3,220,103,462.40 |
January 2011 | $33.54 | 8,992,300 | 89,162,000 | $2,990,154,664.40 |
December 2010 | $32.69 | 11,893,900 | 87,405,000 | $2,857,260,709.50 |
